Back to Agenda
Clinical Development Partnering 2.0 – Multi-Stakeholder Efforts to Reduce Investigator Site Burden
Session Chair(s)
Diana Foster, BSN, PhD, MSN
Chief Executive Officer
TOTAL Diversity Clinical Trial Management, United States
Our Industry is celebrating some amazing achievements - pharmaceutical organisations are spending more than ever on R&D, product pipelines have nearly doubled in the past 10 years, and innovation is being highlighted every single day. Despite these successes, clinical research remains costly and inefficient. Site Investigators continue to face significant challenges in working with CROs and Sponsors. Could collaboration drive the change so desperately needed in the industry? This session will explore the efforts underway between three industry organisations that are working together to reduce administrative burdens placed on investigator sites, and increase study success. Please join leaders from the Society for Clinical Research Sites (SCRS), The Association of Clinical Research Organizations (ACRO) and TransCelerate BioPharma, Inc. to better understand solutions that will address protocol complexity, monitoring structures, communications, contracts, and budgets.
Speaker(s)
Nina Agnes Pruitt, MA
Clinical Ink, United States
VP, Global Strategic Marketing
Reducing Administrative Burdens in the Conduct of Research: A CRO Perspective
Karen A Noonan, MA
Association of Clinical Research Organizations (ACRO), United States
Senior Vice President, Global Regulatory Policy
Transformation through Collaboration
Paul Duffy, BSN, MA
MSD/Transcelerate European Representative, United Kingdom
Director Clinical Research UK & Ireland, MSD UK
Diana Foster, BSN, PhD, MSN
TOTAL Diversity Clinical Trial Management, United States
Chief Executive Officer
How Site Master Data Can Improve the Working Relationship between Sites, Sponsors and CROs
Andrew Gebbie
Medidata Soulutions Worldwide, United Kingdom
Principal Solution Consultant
Have an account?